ID GREB1_HUMAN Reviewed; 1949 AA. AC Q4ZG55; A6NHD0; A6NKN0; B5MDA9; O60321; Q7Z5S2; Q9H2Q6; Q9H2Q7; Q9H2Q8; DT 26-FEB-2008, integrated into UniProtKB/Swiss-Prot. DT 07-JUN-2005, sequence version 1. DT 24-JAN-2024, entry version 117. DE RecName: Full=Protein GREB1; DE AltName: Full=Gene regulated in breast cancer 1 protein; GN Name=GREB1; Synonyms=KIAA0575; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), AND NUCLEOTIDE SEQUENCE RP [MRNA] OF 1-1001 (ISOFORM 1). RC TISSUE=Mammary carcinoma; RX PubMed=11103799; RA Ghosh M.G., Thompson D.A., Weigel R.J.; RT "PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone- RT responsive breast cancer."; RL Cancer Res. 60:6367-6375(2000). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4). RC TISSUE=Brain; RX PubMed=9628581; DOI=10.1093/dnares/5.1.31; RA Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N., RA Ohara O.; RT "Prediction of the coding sequences of unidentified human genes. IX. The RT complete sequences of 100 new cDNA clones from brain which can code for RT large proteins in vitro."; RL DNA Res. 5:31-39(1998). RN [3] RP SEQUENCE REVISION. RA Ohara O., Nagase T., Ishikawa K.; RL Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15815621; DOI=10.1038/nature03466; RA Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., RA Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., RA Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., RA Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., RA Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., RA Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., RA Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., RA Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., RA Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., RA McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., RA Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., RA Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., RA Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., RA Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., RA Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., RA Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., RA Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., RA Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., RA Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., RA Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., RA Wilson R.K.; RT "Generation and annotation of the DNA sequences of human chromosomes 2 and RT 4."; RL Nature 434:724-731(2005). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS THR-77 AND RP ASN-1687. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND VARIANTS THR-77 AND RP ASN-1687. RC TISSUE=Skin; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP INDUCTION BY ESTROGEN. RX PubMed=15345050; DOI=10.1186/gb-2004-5-9-r66; RA Lin C.-Y., Stroem A., Vega V.B., Kong S.L., Yeo A.L., Thomsen J.S., RA Chan W.C., Doray B., Bangarusamy D.K., Ramasamy A., Vergara L.A., Tang S., RA Chong A., Bajic V.B., Miller L.D., Gustafsson J.-A., Liu E.T.; RT "Discovery of estrogen receptor alpha target genes and response elements in RT breast tumor cells."; RL Genome Biol. 5:R66.1-R66.18(2004). RN [8] RP POSSIBLE FUNCTION, AND INDUCTION BY ESTROGEN. RX PubMed=15986123; DOI=10.1007/s10549-005-1483-4; RA Rae J.M., Johnson M.D., Scheys J.O., Cordero K.E., Larios J.M., RA Lippman M.E.; RT "GREB 1 is a critical regulator of hormone dependent breast cancer RT growth."; RL Breast Cancer Res. Treat. 92:141-149(2005). RN [9] RP TISSUE SPECIFICITY, AND INDUCTION. RX PubMed=16496412; DOI=10.1002/pros.20403; RA Rae J.M., Johnson M.D., Cordero K.E., Scheys J.O., Larios J.M., RA Gottardis M.M., Pienta K.J., Lippman M.E.; RT "GREB1 is a novel androgen-regulated gene required for prostate cancer RT growth."; RL Prostate 66:886-894(2006). RN [10] RP INDUCTION BY ESTROGEN. RX PubMed=17463000; DOI=10.1074/jbc.c700030200; RA Deschenes J., Bourdeau V., White J.H., Mader S.; RT "Regulation of GREB1 transcription by estrogen receptor alpha through a RT multipartite enhancer spread over 20 kb of upstream flanking sequences."; RL J. Biol. Chem. 282:17335-17339(2007). RN [11] RP INDUCTION BY ESTROGEN. RX PubMed=17666587; DOI=10.1210/me.2007-0082; RA Sun J., Nawaz Z., Slingerland J.M.; RT "Long-range activation of GREB1 by estrogen receptor via three distal RT consensus estrogen-responsive elements in breast cancer cells."; RL Mol. Endocrinol. 21:2651-2662(2007). CC -!- FUNCTION: May play a role in estrogen-stimulated cell proliferation. CC Acts as a regulator of hormone-dependent cancer growth in breast and CC prostate cancers. CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Single-pass membrane CC protein {ECO:0000255}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=4; CC Name=1; Synonyms=GREB1a; CC IsoId=Q4ZG55-1; Sequence=Displayed; CC Name=2; Synonyms=GREB1b; CC IsoId=Q4ZG55-2; Sequence=VSP_031760, VSP_031761; CC Name=3; Synonyms=GREB1c; CC IsoId=Q4ZG55-3; Sequence=VSP_031758, VSP_031759; CC Name=4; CC IsoId=Q4ZG55-4; Sequence=VSP_031757; CC -!- TISSUE SPECIFICITY: Expressed in proliferating prostatic tissue and CC prostate cancer. {ECO:0000269|PubMed:16496412}. CC -!- INDUCTION: Estrogen-responsive; regulated by estrogen receptors. CC Regulated by androgens. The regulatory region of the gene contains 3 CC estrogen-responsive elements. {ECO:0000269|PubMed:15345050, CC ECO:0000269|PubMed:15986123, ECO:0000269|PubMed:16496412, CC ECO:0000269|PubMed:17463000, ECO:0000269|PubMed:17666587}. CC -!- SIMILARITY: Belongs to the GREB1 family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=BAA25501.2; Type=Erroneous initiation; Evidence={ECO:0000305}; CC -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and CC Haematology; CC URL="https://atlasgeneticsoncology.org/gene/40751/GREB1"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF245388; AAG39036.1; -; mRNA. DR EMBL; AF245389; AAG39037.1; -; mRNA. DR EMBL; AF245390; AAG39038.1; -; mRNA. DR EMBL; AB011147; BAA25501.2; ALT_INIT; mRNA. DR EMBL; AC011994; AAX88907.1; -; Genomic_DNA. DR EMBL; AC110754; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471053; EAX00927.1; -; Genomic_DNA. DR EMBL; CH471053; EAX00928.1; -; Genomic_DNA. DR EMBL; BC054502; AAH54502.1; -; mRNA. DR CCDS; CCDS33146.1; -. [Q4ZG55-2] DR CCDS; CCDS33147.1; -. [Q4ZG55-3] DR CCDS; CCDS42655.1; -. [Q4ZG55-1] DR PIR; T00340; T00340. DR RefSeq; NP_055483.2; NM_014668.3. [Q4ZG55-1] DR RefSeq; NP_149081.1; NM_033090.2. [Q4ZG55-2] DR RefSeq; NP_683701.2; NM_148903.2. [Q4ZG55-3] DR RefSeq; XP_005246249.1; XM_005246192.4. [Q4ZG55-1] DR RefSeq; XP_011508725.1; XM_011510423.2. [Q4ZG55-2] DR AlphaFoldDB; Q4ZG55; -. DR BioGRID; 115040; 27. DR IntAct; Q4ZG55; 15. DR MINT; Q4ZG55; -. DR STRING; 9606.ENSP00000370896; -. DR iPTMnet; Q4ZG55; -. DR PhosphoSitePlus; Q4ZG55; -. DR BioMuta; GREB1; -. DR DMDM; 74739248; -. DR EPD; Q4ZG55; -. DR MassIVE; Q4ZG55; -. DR MaxQB; Q4ZG55; -. DR PaxDb; 9606-ENSP00000370896; -. DR PeptideAtlas; Q4ZG55; -. DR ProteomicsDB; 62378; -. [Q4ZG55-1] DR ProteomicsDB; 62379; -. [Q4ZG55-2] DR ProteomicsDB; 62380; -. [Q4ZG55-3] DR ProteomicsDB; 62381; -. [Q4ZG55-4] DR Antibodypedia; 26843; 193 antibodies from 23 providers. DR DNASU; 9687; -. DR Ensembl; ENST00000234142.9; ENSP00000234142.5; ENSG00000196208.14. [Q4ZG55-1] DR Ensembl; ENST00000263834.9; ENSP00000263834.5; ENSG00000196208.14. [Q4ZG55-3] DR Ensembl; ENST00000381483.6; ENSP00000370892.2; ENSG00000196208.14. [Q4ZG55-2] DR Ensembl; ENST00000381486.7; ENSP00000370896.2; ENSG00000196208.14. [Q4ZG55-1] DR Ensembl; ENST00000396123.2; ENSP00000379429.1; ENSG00000196208.14. [Q4ZG55-4] DR GeneID; 9687; -. DR KEGG; hsa:9687; -. DR MANE-Select; ENST00000381486.7; ENSP00000370896.2; NM_014668.4; NP_055483.2. DR UCSC; uc002rbk.2; human. [Q4ZG55-1] DR AGR; HGNC:24885; -. DR CTD; 9687; -. DR DisGeNET; 9687; -. DR GeneCards; GREB1; -. DR HGNC; HGNC:24885; GREB1. DR HPA; ENSG00000196208; Tissue enriched (ovary). DR MIM; 611736; gene. DR neXtProt; NX_Q4ZG55; -. DR OpenTargets; ENSG00000196208; -. DR PharmGKB; PA164747489; -. DR VEuPathDB; HostDB:ENSG00000196208; -. DR eggNOG; ENOG502QQXD; Eukaryota. DR GeneTree; ENSGT00390000008041; -. DR HOGENOM; CLU_237163_0_0_1; -. DR InParanoid; Q4ZG55; -. DR OMA; YIMQHIE; -. DR OrthoDB; 2901969at2759; -. DR PhylomeDB; Q4ZG55; -. DR TreeFam; TF329531; -. DR PathwayCommons; Q4ZG55; -. DR Reactome; R-HSA-9018519; Estrogen-dependent gene expression. DR SignaLink; Q4ZG55; -. DR SIGNOR; Q4ZG55; -. DR BioGRID-ORCS; 9687; 10 hits in 1153 CRISPR screens. DR ChiTaRS; GREB1; human. DR GenomeRNAi; 9687; -. DR Pharos; Q4ZG55; Tbio. DR PRO; PR:Q4ZG55; -. DR Proteomes; UP000005640; Chromosome 2. DR RNAct; Q4ZG55; Protein. DR Bgee; ENSG00000196208; Expressed in left ovary and 161 other cell types or tissues. DR ExpressionAtlas; Q4ZG55; baseline and differential. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005654; C:nucleoplasm; TAS:Reactome. DR InterPro; IPR028422; GREB1. DR InterPro; IPR048659; GREB1-like_2nd. DR InterPro; IPR046927; GREB1-like_C. DR InterPro; IPR048657; GREB1-like_cpSF2. DR InterPro; IPR046926; GREB1_N. DR InterPro; IPR049100; TAGT. DR PANTHER; PTHR15720; GREB1-RELATED; 1. DR PANTHER; PTHR15720:SF13; PROTEIN GREB1; 1. DR Pfam; PF20692; cpSF2-GREB1; 1. DR Pfam; PF20688; GREB1_2nd; 1. DR Pfam; PF20267; GREB1_C; 1. DR Pfam; PF15782; GREB1_N; 1. DR Pfam; PF20691; TAGT; 1. DR Genevisible; Q4ZG55; HS. PE 2: Evidence at transcript level; KW Alternative splicing; Membrane; Reference proteome; Transmembrane; KW Transmembrane helix. FT CHAIN 1..1949 FT /note="Protein GREB1" FT /id="PRO_0000320944" FT TRANSMEM 1868..1888 FT /note="Helical" FT /evidence="ECO:0000255" FT REGION 52..77 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 302..334 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1085..1210 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1085..1126 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1127..1155 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1183..1210 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT VAR_SEQ 1..1002 FT /note="Missing (in isoform 4)" FT /evidence="ECO:0000303|PubMed:15489334, FT ECO:0000303|PubMed:9628581" FT /id="VSP_031757" FT VAR_SEQ 387..409 FT /note="GHGNFPYLCGNLNDVVVSPLLYT -> VFVNGATQMVALGPAEPASPRSL FT (in isoform 3)" FT /evidence="ECO:0000303|PubMed:11103799" FT /id="VSP_031758" FT VAR_SEQ 410..1949 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|PubMed:11103799" FT /id="VSP_031759" FT VAR_SEQ 450..457 FT /note="ADQVPLME -> HQIRNPDV (in isoform 2)" FT /evidence="ECO:0000303|PubMed:11103799" FT /id="VSP_031760" FT VAR_SEQ 458..1949 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:11103799" FT /id="VSP_031761" FT VARIANT 77 FT /note="N -> T (in dbSNP:rs10929757)" FT /evidence="ECO:0000269|PubMed:15489334, ECO:0000269|Ref.5" FT /id="VAR_039313" FT VARIANT 122 FT /note="V -> A (in dbSNP:rs4669751)" FT /id="VAR_039314" FT VARIANT 346 FT /note="V -> M (in dbSNP:rs6744817)" FT /id="VAR_039315" FT VARIANT 359 FT /note="F -> L (in dbSNP:rs35188552)" FT /id="VAR_061654" FT VARIANT 632 FT /note="A -> T (in dbSNP:rs36030386)" FT /id="VAR_061655" FT VARIANT 973 FT /note="R -> Q (in dbSNP:rs3762579)" FT /id="VAR_039316" FT VARIANT 1463 FT /note="Y -> C (in dbSNP:rs11695925)" FT /id="VAR_039317" FT VARIANT 1687 FT /note="D -> N (in dbSNP:rs2304402)" FT /evidence="ECO:0000269|PubMed:15489334, ECO:0000269|Ref.5" FT /id="VAR_039318" FT VARIANT 1814 FT /note="L -> V (in dbSNP:rs34955282)" FT /id="VAR_039319" FT CONFLICT 829 FT /note="I -> S (in Ref. 1; AAG39036)" FT /evidence="ECO:0000305" SQ SEQUENCE 1949 AA; 216467 MW; BA12C0535B166BC4 CRC64; MGNSYAGQLK TTRFEEVLHN SIEASLRSNN LVPRPIFSQL YLEAEQQLAA LEGGSRVDNE EEEEEGEGGL ETNGPPNPFQ LHPLPEGCCT TDGFCQAGKD LRLVSISNEP MDVPAGFLLV GVKSPSLPDH LLVCAVDKRF LPDDNGHNAL LGFSGNCVGC GKKGFCYFTE FSNHINLKLT TQPKKQKHLK YYLVRNAQGT LTKGPLICWK GSEFRSRQIP ASTCSSSLFP ALESTAAFPS EPVPGTNPSI LMGAQQAGPA SDHPSLNAAM GPAVFNGKDS PKCQQLAKNN LLALPRPSAL GILSNSGPPK KRHKGWSPES PSAPDGGCPQ GGGNRAKYES AGMSCVPQVG LVGPASVTFP VVASGEPVSV PDNLLKICKA KPVIFKGHGN FPYLCGNLND VVVSPLLYTC YQNSQSVSRA YEQYGASAIQ PISEEMQLLL TVYYLVQLAA DQVPLMEDLE QIFLRSWRES HLTEIRQYQQ APPQPFPPAP SAAAPVTSAQ LPWLASLAAS SCNDSVHVIE CAYSLAEGLS EMFRLLVEGK LAKTNYVVII CACRSAAIDS CIAVTGKYQA RILSESLLTP AEYQKEVNYE LVTGKVDSLG AFFSTLCPEG DIDILLDKFH QENQGHISSS LAASSVTKAA SLDVSGTPVC TSYNLEPHSI RPFQLAVAQK LLSHVCSIAD SSTQNLDLGS FEKVDFLICI PPSEVTYQQT LLHVWHSGVL LELGLKKEHM TKQRVEQYVL KLDTEAQTKF KAFLQNSFQN PHTLFVLIHD HAHWDLVSST VHNLYSQSDP SVGLVDRLLN CREVKEAPNI VTLHVTSFPY ALQTQHTLIS PYNEIHWPAS CSNGVDLYHE NKKYFGLSEF IESTLSGHSL PLLRYDSSFE AMVTALGKRF PRLHSAVIRT FVLVQHYAAA LMAVSGLPQM KNYTSVETLE ITQNLLNSPK QCPCGHGLMV LLRVPCSPLA VVAYERLAHV RARLALEEHF EIILGSPSSG VTVGKHFVKQ LRMWQKIEDV EWRPQTYLEL EGLPCILIFS GMDPHGESLP RSLRYCDLRL INSSCLVRTA LEQELGLAAY FVSNEVPLEK GARNEALESD AEKLSSTDNE DEELGTEGST SEKRSPMKRE RSRSHDSASS SLSSKASGSA LGGESSAQPT ALPQGEHARS PQPRGPAEEG RAPGEKQRPR ASQGPPSAIS RHSPGPTPQP DCSLRTGQRS VQVSVTSSCS QLSSSSGSSS SSVAPAAGTW VLQASQCSLT KACRQPPIVF LPKLVYDMVV STDSSGLPKA ASLLPSPSVM WASSFRPLLS KTMTSTEQSL YYRQWTVPRP SHMDYGNRAE GRVDGFHPRR LLLSGPPQIG KTGAYLQFLS VLSRMLVRLT EVDVYDEEEI NINLREESDW HYLQLSDPWP DLELFKKLPF DYIIHDPKYE DASLICSHYQ GIKSEDRGMS RKPEDLYVRR QTARMRLSKY AAYNTYHHCE QCHQYMGFHP RYQLYESTLH AFAFSYSMLG EEIQLHFIIP KSKEHHFVFS QPGGQLESMR LPLVTDKSHE YIKSPTFTPT TGRHEHGLFN LYHAMDGASH LHVLVVKEYE MAIYKKYWPN HIMLVLPSIF NSAGVGAAHF LIKELSYHNL ELERNRQEEL GIKPQDIWPF IVISDDSCVM WNVVDVNSAG ERSREFSWSE RNVSLKHIMQ HIEAAPDIMH YALLGLRKWS SKTRASEVQE PFSRCHVHNF IILNVDLTQN VQYNQNRFLC DDVDFNLRVH SAGLLLCRFN RFSVMKKQIV VGGHRSFHIT SKVSDNSAAV VPAQYICAPD SKHTFLAAPA QLLLEKFLQH HSHLFFPLSL KNHDHPVLSV DCYLNLGSQI SVCYVSSRPH SLNISCSDLL FSGLLLYLCD SFVGASFLKK FHFLKGATLC VICQDRSSLR QTVVRLELED EWQFRLRDEF QTANAREDRP LFFLTGRHI //